Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Philippines New Round Of Voluntary Price Cuts Of 97 Drugs Takes Effect

This article was originally published in PharmAsia News

Executive Summary

The Philippines announced voluntary offers by several drug companies to cut the price levels on 97 drugs as part of the government's second Cheaper Medicines Act effort

The Philippines announced voluntary offers by several drug companies to cut the price levels on 97 drugs as part of the government's second Cheaper Medicines Act effort.

The Government Mediated Access Price includes five dialysis devices not on an original list, with the new ones set to cost 30 percent less. The new prices became effective March 31, covering several categories of drugs, including those intended for cholesterol, cancer, asthma eye problems and pain relievers. The Pharmaceutical and Healthcare Association of the Philippines has requested a review of the impact of the cuts on improving access by the poor. (Click here for more)

"New Drug Price Cut Takes Effect" - Business World (Philippines) (3/31/10)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC074505

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel